Arginine depletion as a therapeutic approach for patients with COVID-19
The COVID-19 pandemic, caused by SARS-CoV-2, is a source of significant morbidity and mortality worldwide, and effective treatments are urgently needed. Clinical trials have largely focused on direct anti-viral therapies or on immunomodulation in patients with severe manifestations of COVID-19. One...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/15606
- Acceso en línea:
- https://doi.org/10.1016/j.ijid.2020.10.100
http://hdl.handle.net/20.500.12010/15606
- Palabra clave:
- COVID-19
Pandemic
SARS-CoV-2
Clinical trials
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)